- Report
- March 2024
- 189 Pages
Global
From €3283EUR$3,374USD£2,812GBP
€3648EUR$3,749USD£3,125GBP
- Report
- January 2024
- 175 Pages
Global
From €4865EUR$5,000USD£4,168GBP
- Report
- February 2024
- 175 Pages
Global
From €4865EUR$5,000USD£4,168GBP
- Report
- February 2024
- 175 Pages
Global
From €4865EUR$5,000USD£4,168GBP
- Clinical Trials
- April 2024
- 440 Pages
Global
From €4865EUR$5,000USD£4,168GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1946EUR$2,000USD£1,667GBP
- Clinical Trials
- April 2024
- 200 Pages
Global
€4865EUR$5,000USD£4,168GBP
- Drug Pipelines
- April 2024
- 210 Pages
Global
From €2432EUR$2,500USD£2,084GBP
- Report
- December 2022
- 153 Pages
Global
From €5108EUR$5,250USD£4,376GBP
- Report
- December 2018
- 83 Pages
Global
From €5789EUR$5,950USD£4,959GBP
- Report
- April 2023
- 120 Pages
Global
From €4622EUR$4,750USD£3,959GBP
- Report
- April 2018
- 112 Pages
Global
From €4135EUR$4,250USD£3,542GBP
- Report
- April 2023
- 200 Pages
United States
From €3649EUR$3,750USD£3,126GBP
- Report
- April 2023
- 394 Pages
Global
From €7297EUR$7,500USD£6,251GBP
- Report
- May 2020
- 482 Pages
Global
From €9243EUR$9,500USD£7,918GBP
- Report
- November 2022
- 117 Pages
Global
From €4768EUR$4,900USD£4,084GBP
- Report
- August 2022
- 116 Pages
Global
From €4378EUR$4,500USD£3,751GBP
- Report
- March 2018
- 90 Pages
North America
From €3746EUR$3,850USD£3,209GBP
- Report
- May 2023
- 93 Pages
Global
From €3500EUR$3,853USD£3,103GBP
- Report
- June 2021
- 99 Pages
Global
From €3200EUR$3,523USD£2,837GBP
Carboplatin is a chemotherapy drug used to treat lung cancer. It is a platinum-based drug, which works by interfering with the growth of cancer cells. It is often used in combination with other drugs, such as paclitaxel, to treat non-small cell lung cancer. Carboplatin is also used to treat other types of cancer, such as ovarian and bladder cancer.
Carboplatin is generally well-tolerated, with fewer side effects than other chemotherapy drugs. Common side effects include nausea, vomiting, and hair loss. It is important to note that Carboplatin can cause serious side effects, such as kidney damage and hearing loss.
The Carboplatin market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Pfizer, Bristol-Myers Squibb, Merck, and AstraZeneca. Other companies, such as Teva Pharmaceuticals and Mylan, also offer generic versions of Carboplatin. Show Less Read more